Yonhap Infomax NewsJan 26
Samsung Bioepis posts sharp 60% year-on-year drop in Q4 operating profit, signaling challenges for South Korea's biosimilar sector.
#YonhapInfomax #SamsungBioepis #OperatingProfit #Q4Earnings #Biosimilar #YearOnYearDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102024
Samsung Bioepis Q4 Operating Profit Plunges 60% to 29.2 Billion Won

Samsung Bioepis posts sharp 60% year-on-year drop in Q4 operating profit, signaling challenges for South Korea's biosimilar sector.

Yonhap Infomax